Several risk factors can increase the likelihood of developing TLS, including high tumor burden, high proliferation rate of the tumor, pre-existing kidney dysfunction, elevated levels of uric acid, and elevated lactate dehydrogenase (LDH). Additionally, high doses of cytotoxic therapy or the use of highly effective treatments can precipitate TLS.
